Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schaefer APA, Sustr V, Willinger B, Mendling W.
Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27.
Candidiasis (vulvovaginal).
Martin Lopez JE.
BMJ Clin Evid. 2015 Mar 16;2015:0815.
Acute vulvovaginitis.
Shirley RL.
N Engl J Med. 2006 Dec 28;355(26):2791; author reply 2791. doi: 10.1056/NEJMc062854.
Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
MacAlpine J, Lionakis MS.
Cell Host Microbe. 2024 Oct 9;32(10):1654-1667. doi: 10.1016/j.chom.2024.08.018.
Ibrexafungerp to treat acute vulvovaginal candidiasis.
Masone MC.
Nat Rev Urol. 2021 Nov;18(11):638. doi: 10.1038/s41585-021-00522-9.
Candidiasis (vulvovaginal).
Spence D.
BMJ Clin Evid. 2010 Jan 5;2010:0815.
Candidiasis (vulvovaginal).
Spence D.
BMJ Clin Evid. 2007 Feb 1;2007:0815.
Clinical practice. Acute vulvovaginitis.
Eckert LO.
N Engl J Med. 2006 Sep 21;355(12):1244-52. doi: 10.1056/NEJMcp053720.
Recurrent vulvovaginal candidiasis.
Ringdahl EN.
Mo Med. 2006 Mar-Apr;103(2):165-8.
Granulomatous Vulvitis: A Rare Case of Chronic Inflammatory Hypertrophy of Vulvar Labia Related to Ulcerative Colitis.
Soni S, Yadav V, Mendiratta V, Yadav J, Osama MA, Singh S.
Indian Dermatol Online J. 2023 Aug 10;14(5):679-681. doi: 10.4103/idoj.idoj_564_22. eCollection 2023 Sep-Oct.
